You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 150 No. 10, October 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (23)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pregnancy in Women With Immune Thrombocytopenic Purpura

Alexandra Moutet, MD; Patricia Fromont, BSc; Jean-Pierre Farcet, MD; Daniel Rotten, MD; Ali Bettaieb, PhD; Najib Duédari, MD; Philippe Bierling, MD

Arch Intern Med. 1990;150(10):2141-2145.


Abstract

• Thirty-six women with immune thrombocytopenic purpura were studied during 37 pregnancies, and maternal characteristics with predictive value for the fetal platelet count were determined. Nine neonates were thrombocytopenic, with a platelet count of less than 50 x 109/L in eight. Four of these nine neonates delivered to a subgroup of 31 mothers were studied prospectively; the frequency of thrombocytopenia in neonates of women with immune thrombocytopenic purpura was thus 13%. Only two of these nine neonates presented with hemorrhagic syndromes (two, petechial purpura; one, intracranial bleeding). The frequency of neonatal thrombocytopenia was higher in mothers with deep thrombocytopenia and in those who had not responded to corticosteroid treatment following diagnosis. No prognostic value could be assigned to the other maternal characteristics studied, such as a history of splenectomy, maternal treatment at the time of delivery, or the presence of platelet autoantibodies evaluated either with the platelet immunofluorescence test or the platelet Western blot immunoassay.

(Arch Intern Med. 1990;150:2141-2145)



Author Affiliations

From the Blood Center (Drs Moutet, Duédari, and Bierling, Ms Fromont, and Mr Bettaieb) and the Department of Immunology (Drs Farcet, Duédari, and Bierling), Henri Mondor Hospital, and the Department of Obstetrics, Centre Hospitalier Intercommunal (Dr Rotten), Créteil, France.


Footnotes

Accepted for publication March 18, 1990.

Reprint requests to Centre de Transfusion, Hôpital Henri Mondor, 51, avenue de Maréchal de Lattre de Tassigny, 94010 Créteil, France (Dr Bierling).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura
Webert et al.
Blood 2003;102:4306-4311.
ABSTRACT | FULL TEXT  

Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia
Burrows and Kelton
NEJM 1993;329:1463-1466.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.